IL6 and inflammatory bowel disease: A disrupted microbiota in IBD is associated with elevated proinflammatory cytokines (including TNF-α and IL-6) and the activation of inflammatory signaling pathways like nuclear factor kappa B (NF-κB), contributing to sustained gastrointestinal inflammation [114].